South Korea Car-T Cell Therapy Market Size

Market Size in USD Mn

CAGR16.3%

Study Period	2025-2032
Base Year of Estimation	2024
CAGR	16.3%
Market Concentration	Medium
Major Players	Novartis AG, Pfizer, Inc., Bristol Myers Squibb, CARsgen Therapeutics Co., Ltd., Fate Therapeutics, Inc. and Among Others

*Disclaimer: Major players are listed in no particular order.

*Source: Coherent Market Insights

Want to purchase customized report?
please let us know !

South Korea Car-T Cell Therapy Market Analysis

The South Korea Car-T Cell Therapy Market is estimated to be valued at USD 9.2 Mn in 2025 and is expected to reach USD 26.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032.

With successful treatment of hematologic malignancies and rising investment by both public and private players in developing CAR-T therapies, the market is expected to witness steady growth.